Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
Shirin T, Bhuiyan TR, Charles RC, Amin S, Bhuiyan I, Kawser Z, Rahat A, Alam AN, Sultana S, Aleem MA, Khan MH, Khan SR, LaRocque RC, Calderwood SB, Ryan ET, Slater DM, Banu S, Clemens J, Harris JB, Flora MS, Qadri F. Shirin T, et al. Among authors: clemens j. Int J Infect Dis. 2020 Dec;101:220-225. doi: 10.1016/j.ijid.2020.09.1484. Epub 2020 Oct 5. Int J Infect Dis. 2020. PMID: 33031941 Free PMC article.
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.
Akter A, Ahmed T, Tauheed I, Akhtar M, Rahman SIA, Khaton F, Ahmmed F, Ferdous J, Afrad MH, Kawser Z, Hossain M, Khondaker R, Hasnat MA, Sumon MA, Rashed A, Ghosh S, Calderwood SB, Charles RC, Ryan ET, Khatri P, Maecker HT, Obermoser G, Pulendran B, Clemens JD, Banu S, Shirin T, LaRocque RC, Harris JB, Bhuiyan TR, Chowdhury F, Qadri F. Akter A, et al. Among authors: clemens jd. PLoS Negl Trop Dis. 2022 Jan 4;16(1):e0010102. doi: 10.1371/journal.pntd.0010102. eCollection 2022 Jan. PLoS Negl Trop Dis. 2022. PMID: 34982773 Free PMC article.
Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014.
Chowdhury F, Mather AE, Begum YA, Asaduzzaman M, Baby N, Sharmin S, Biswas R, Uddin MI, LaRocque RC, Harris JB, Calderwood SB, Ryan ET, Clemens JD, Thomson NR, Qadri F. Chowdhury F, et al. PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004183. doi: 10.1371/journal.pntd.0004183. eCollection 2015 Nov. PLoS Negl Trop Dis. 2015. PMID: 26562418 Free PMC article.
Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.
Bhuiyan TR, Al Banna H, Kaisar MH, Karmakar PC, Hakim A, Akter A, Ahmed T, Tauheed I, Islam S, Hasnat MA, Sumon MA, Rashed A, Ghosh S, Clemens JD, Banu S, Shirin T, Weiskopf D, Sette A, Chowdhury F, Qadri F. Bhuiyan TR, et al. Front Immunol. 2022 Sep 28;13:929849. doi: 10.3389/fimmu.2022.929849. eCollection 2022. Front Immunol. 2022. PMID: 36248882 Free PMC article.
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.
Qadri F, Chowdhury MI, Faruque SM, Salam MA, Ahmed T, Begum YA, Saha A, Alam MS, Zaman K, Seidlein LV, Park E, Killeen KP, Mekalanos JJ, Clemens JD, Sack DA; Peru-15 Study Group. Qadri F, et al. Among authors: clemens jd. J Infect Dis. 2005 Aug 15;192(4):573-9. doi: 10.1086/432074. Epub 2005 Jul 15. J Infect Dis. 2005. PMID: 16028125 Clinical Trial.
The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants.
Saha A, Khan A, Salma U, Jahan N, Bhuiyan TR, Chowdhury F, Khan AI, Khanam F, Muruganandham S, Reddy Kandukuri S, Singh Dhingra M, Clemens JD, Cravioto A, Qadri F. Saha A, et al. Vaccine. 2016 Mar 18;34(13):1551-1558. doi: 10.1016/j.vaccine.2016.02.020. Epub 2016 Feb 16. Vaccine. 2016. PMID: 26896684 Clinical Trial.
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
Qadri F, Ali M, Lynch J, Chowdhury F, Khan AI, Wierzba TF, Excler JL, Saha A, Islam MT, Begum YA, Bhuiyan TR, Khanam F, Chowdhury MI, Khan IA, Kabir A, Riaz BK, Akter A, Khan A, Asaduzzaman M, Kim DR, Siddik AU, Saha NC, Cravioto A, Singh AP, Clemens JD. Qadri F, et al. Among authors: clemens jd. Lancet Infect Dis. 2018 Jun;18(6):666-674. doi: 10.1016/S1473-3099(18)30108-7. Epub 2018 Mar 14. Lancet Infect Dis. 2018. PMID: 29550406 Free article. Clinical Trial.
1,354 results